ASCO 2016 | Improved overall survival in lung cancer patients using Moovcare compared to standard modalities
Press brief by Fabrice Denis, MD, PhD of the Jean Bernard Center, Le Mans, France, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Get great new content delivered to your inboxSign up
BTOG 2020: what to expect
Pharmacy perspective: pembrolizumab monotherapy 6 weekly dosing
Minimizing the risk of steroid-induced hyperglycemia in NSCLC patients receiving immunotherapy
SB8: a bevacizumab biosimilar for NSCLC
The immunotherapy NSCLC revolution